Brief: Active Biotech: FDA grants Orphan Drug Designation for tasquinimod for multiple myeloma treatment

Active Biotech AB publ

12/04/2017 12:31

April 12 (Reuters) - Active Biotech Ab  ACTI.ST  
    * Reg-Active biotech: fda grants orphan drug designation for 
tasquinimod for the treatment of multiple myeloma 
 
Source text for Eikon:  ID:nGNEbyGKvr  
Further company coverage:  ACTI.ST  
 
 (Reporting By Anna Ringstrom) 
 ((Anna.Ringstrom@thomsonreuters.com;))